CLPT 8-K
ClearPoint Neuro, Inc. (CLPT)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
As part of a regular review of the corporate governance practices of ClearPoint Neuro, Inc. (the “Company”) and in an effort to continue to attract and retain qualified members of the Company’s Board of Directors (the “Board”), which includes compensating members appropriately for their services, the Compensation Committee of the Board recommended to the Board, and the Board approved revisions to the ClearPoint Neuro, Inc. Non-Employee Director Compensation Plan (the “Director Plan”), which provides annual cash and equity compensation, on the terms and conditions contained therein. The Director Plan had last been revised on May 22, 2023.
The foregoing description of the amended Director Plan is only a summary and is qualified in its entirety by the full text of the amended Director Plan, the form of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. |
Description |
|
||
|
|
|
||
10.1 |
||||
|
|
|||
104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
|||
|
|
|
||
|
|
|
||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
CLEARPOINT NEURO, INC. |
|
|
|
|
Date: |
May 19, 2025 |
By: |
/s/ Danilo D'Alessandro |
|
|
|
Danilo D'Alessandro |
Exhibit 10.1
CLEARPOINT NEURO, INC.
NON-EMPLOYEE DIRECTOR COMPENSATION PLAN
This Non-Employee Director Compensation Plan (this “Plan”) sets forth the compensation for non-employee members of the Board of Directors (the “Board”) of ClearPoint Neuro, Inc. (the “Company”). This Plan applies only to non-employee members of the Board and is not applicable to employee members of the Board. This Plan will remain in effect until it is revised or rescinded by further action of the Board.
Retainers and Meeting Fees
The following table sets forth the fees to be paid to the non-employee directors of the Company:
Board of Directors: |
|
|
||
Annual retainer for chairperson |
|
$ |
75,000 |
|
Annual retainer for the other members |
|
$ |
45,000 |
* |
|
|
|
|
|
Audit Committee: |
|
|
|
|
Annual retainer for chairperson |
|
$ |
20,000 |
|
Annual retainer for the other members |
|
$ |
10,000 |
|
|
|
|
|
|
Compensation Committee: |
|
|
|
|
Annual retainer for chairperson |
|
$ |
15,000 |
|
Annual retainer for the other members |
|
$ |
7,500 |
|
|
|
|
|
|
Corporate Governance and Nominating Committee: |
|
|
|
|
Annual retainer for chairperson |
|
$ |
12,000 |
|
Annual retainer for the other members |
|
$ |
7,500 |
|
*Effective July 1, 2025. Prior to July 1, 2025, an annual retainer of $40,000 shall be applicable.
The above retainers shall be paid in quarterly installments, in arrears, on the first business day following the end of the quarter. Each director may elect to have the Company pay all or a portion of his or her fees in shares of the Company’s common stock (“Common Stock”), in lieu of cash, in accordance with the practices established from time to time by the Board. Any such shares of Common Stock issued pursuant to this Plan may consist, in whole or in part, of authorized and unissued shares, treasury shares or shares purchased on the open market.
The Company also reimburses each non-employee director for reasonable travel and other expenses in connection with attending meetings of the Board.
Equity Compensation – New Director One-Time Grant
Upon an individual becoming a non-employee director for the first time, the new director will receive a restricted stock unit award grant entitling him/her to shares valued at $150,000. Such restricted stock unit awards will vest on the first anniversary of the grant.
Equity Compensation - Annual Grants
Any individual who serves as a non-employee director on the day following an annual meeting of the Company’s stockholders shall receive a restricted stock unit award grant entitling him/her to shares valued at $150,000. Such restricted stock unit awards will vest on the earlier of the first anniversary of the grant date or the day immediately preceding the next annual meeting of stockholders.
Plan Revision History